Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Back
Scientific Session

Vasculitis
General Topic: Clinical Science

14T124: Advancing Non-Invasive Biomarkers in ANCA-Associated Vasculitis and Lupus Nephritis: A Translational State of the Art

Tuesday, November 14, 2023
11:00 AM – 12:00 PM PT
Location: Room 31A-C
CE: 1

In Person On Demand

    Speaker(s)

  • SA

    Salem Almaani, MD, MS

    The Ohio State University Medical Center
    Columbus, OH, United States

    Disclosure(s): Amgen: Consultant (Ongoing); Aurinia: Consultant (Ongoing); Chemocentryx: Consultant (Terminated, January 1, 2023); Gilead: Grant/Research Support (Ongoing); Kezar: Consultant (Ongoing); Otsuka: Consultant (Terminated, April 1, 2023)

  • AF

    Andrea Fava, MD

    Johns Hopkins University
    Baltimore, MD, United States

    Disclosure(s): Annexon Biosciences: Consultant (Ongoing); Sanofi: Advisor or Review Panel Member (Terminated, April 30, 2022)

  • Brad Rovin, MD

    The Ohio State University
    Columbus, OH, United States

    Disclosure(s): AstraZeneca: Consultant (Ongoing), Grant/Research Support (Ongoing); Aurinia: Consultant (Ongoing), Grant/Research Support (Ongoing); Biogen: Consultant (Ongoing); F. Hoffmann-La Roche Ltd: Consultant (Ongoing); Genentech: Consultant (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Novartis: Consultant (Ongoing)

Noninvasive biomarkers can revolutionize diagnosis and treatment monitoring of glomerulonephritides (GNs), such as ANCA-associated GN and lupus nephritis. This session will review the recent major advancements that are leading the way to novel liquid biopsies.

Learning Objectives:

  • Discuss the current challenges in the diagnosis and monitoring with current biomarkers in lupus nephritis and ANCA-associated GN
  • Review the latest discoveries of noninvasive biomarkers of lupus nephritis and ANCA-associated GN
  • Discuss the future clinical applicability of noninvasive biomarkers in lupus nephritis and ANCA-associated GN

Presentations:

  • 11:00 AM – 11:15 AM PT
    Diagnostic Challenges and Monitoring with Current Noninvasive Biomarkers in ANCA-Associated Glomerulonephritis and Lupus Nephritis

    Speaker: Brad Rovin, MD – The Ohio State University

  • 11:15 AM – 11:30 AM PT
    Translating Molecular and Noninvasive Biomarkers for the Diagnosis and Management of ANCA-Associated Glomerulonephritis

    Speaker: Salem Almaani, MD, MS – The Ohio State University Medical Center

  • 11:30 AM – 11:45 AM PT
    Translating Molecular and Noninvasive Biomarkers for the Diagnosis and Management of Lupus Nephritis

    Speaker: Andrea Fava, MD – Johns Hopkins University

  • 11:45 AM – 12:00 PM PT
    Q&A